Does Helicobacter pylori Eradication Therapy Reduce the Risk of Developing Gastric Cancer in Healthy Asymtomatic Individuals?

Yeon-Ji Kim; Woo Chul Chung

doi:10.4166/kjg.2014.64.1.62

Journal List > Korean J Gastroenterol > v.64(1) > 1007325

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kim and Chung: Does Helicobacter pylori Eradication Therapy Reduce the Risk of Developing Gastric Cancer in Healthy Asymtomatic Individuals?

Research Update

Korean J Gastroenterol 2014;64(1):62-65.

Published online: 4 October 2014

DOI: https://doi.org/10.4166/kjg.2014.64.1.62

Does Helicobacter pylori Eradication Therapy Reduce the Risk of Developing Gastric Cancer in Healthy Asymtomatic Individuals?

Yeon-Ji Kim, Woo Chul Chung

Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea

Correspondence to: Woo Chul Chung, Department of Internal Medicine, The Catholic University of Korea, St. Vincent's Hospital, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea. Tel: +82-31-249-7137, Fax: +82-31-253-8898, E-mail: jwchulkr@catholic.ac.kr

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Article

Helicobacter pylori Eradication Therapy to Prevent Gastric Cancer in Healthy Asymptomatic Infected Individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials.

References

1. Correa P. The gastric precancerous process. Cancer Surv. 1983; 2:437–450.

2. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975; 2:58–60.

3. Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009; 151:121–128.

4. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and metaanalysis of randomised controlled trials. BMJ. 2014; 348:g3174.

5. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 2000; 92:1881–1888.

6. Gail MH, Brown LM, You W. Re: chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 2001; 93:559–560.

7. Saito D, Boku N, Fujioka T, et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the japanese intervention trial (JITHP-Study). A randomized multicenter trial. Gastroenterology. 2005; 128(Suppl 2):A4.

8. Wong BC, Lam SK, Wong WM, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004; 291:187–194.

9. Wong BC, Zhang L, Ma JL, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut. 2012; 61:812–818.

10. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012; 104:488–492.

11. Zhou L. Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in China. Gastroenterology. 2008; 134(Suppl 1):A233.

12. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004; 53:1244–1249.

13. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of pre-cancerous gastric lesions. J Natl Cancer Inst. 2006; 98:974–983.

14. Fukase K, Kato M, Kikuchi S, et al. Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008; 372:392–397.

15. Choi J, Kim SG, Yoon H, et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol. 2014; 12:793–800.

16. Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut. 2013; 62:676–682.

Fig. 1.

Forest plot of randomized controlled trials of Helicobacter pylori eradication therapy: effect on subsequent occurrence of gastric cancer. Revised from the article of Ford et al. (BMJ 2014;348:g3174).⁴ df, degree of freedom.

Fig. 2.

Forest plot of randomized controlled trials of Helicobacter pylori eradication therapy: effect on subsequent occurrence of gastric cancer according to presence or absence of pre-neoplastic lesions at baseline. Revised from the article of Ford et al. (BMJ 2014;348:g3174).⁴ df, degree of freedom.

Fig. 3.

Forest plot of randomised controlled trials of Helicobacter pylori eradication therapy: effect on subsequent occurrence of gastric cancer according to anti-oxidant or vitamin use. Revised from the article of Ford et al. (BMJ 2014;348:g3174).⁴ df, degree of freedom.

TOOLS

Similar articles